PanCareLIFE is an EU Framework 7 Programme in the Health Theme that studies the impact of treatment regimes on long-term health and quality of life in survivors of cancer diagnosed during childhood or young adulthood

Survival rates after childhood cancer now reach nearly 80% in developed European countries as a result of more effective therapies and better supportive care, leading to a steady increase in the number of survivors in the population.

However, the treatments that have improved survival are harsh and cause serious side-effects that can greatly impact survivors’ quality of life in the long term.

The goal of PanCareLIFE is that survivors of cancer diagnosed before age 25 should enjoy the same quality of life and opportunities as their peers who have not had cancer.